TITaner İyIgün

Taner İyIgün

*This is an algorithmically generated author record based on publicly available information.

Taner İyIgün has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmet Güner

    Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Türkiye

    1 shared publication
  • Aydin Unal

    University Of Health Sciences Turkey, Istanbul Mehmet Akif Ersoy Thoracic And Cardiovascular Surgery Training And Research Hospital, Cardiovascular Surgery, İstanbul, Turkey

    1 shared publication
  • Barış Timur

    Department of Cardiovascular Surgery, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul 34303, Türkiye

    1 shared publication
  • Burak Onan

    Department of Cardiovascular Surgery, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey

    1 shared publication
  • Ersin Kadi̇rogullari

    University Of Health Sciences Turkey, Istanbul Mehmet Akif Ersoy Thoracic And Cardiovascular Surgery Training And Research Hospital, Cardiovascular Surgery, İstanbul, Turkey

    1 shared publication
  • Gamze Babur Guler

    Department of Cardiology, University of Health Sciences, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Halkali, Istanbul, Turkey

    1 shared publication

Latest Publications

  • Open Access

    Surgical Approach to Moderate to Severe Ischemic Mitral Regurgitation Following the First Myocardial Infarction

    by Barış Timur, Gamze Babur Güler, Tuğba Aktemur, Zihni Mert Duman, Timuçin Aksu, Zinar Apaydın, Taner İyIgün

    Objectives: Ischemic mitral valve regurgitation (IMR) is a subgroup of secondary mitral valve insufficiency that develops due to ischemic heart disease. The aim of the study is to evaluate the patients who were operated after acute myocardial infarction (AMI) for the type of interventions to be performed for the mitral valve in terms of mortality and morbidity. Methods: Patients who were admitted to the hospital with the diagnosis of acute myocardial infarction and operated emergently or urgently between January 2017 and December 2020 were evaluated. Echocardiographic quantitative and qualitative data were measured. Accordingly, patients were evaluated as mild, moderate or severe mitral insufficiency. Patients who were found to have significant IMR (≥ moderate mitral regurgitation) in the early period and who could achieve complete revascularization were included in the study. Patients were divided into two groups whether the mitral valve was intervened or not. Results: The demographical data of the patients that were included in the study is as follows, 73.4% were male and 33% were female. The average age of the patients was 63.2±8.9. Patients were compared in terms of significant postoperative residual mitral regurgitation. 62.2% (n=23) of the patients undergone isolated CABG had mild mitral regurgitation. 5 patients with mitral valve annuloplasty (17.9%) had significant residual regurgitation (pConclusion: Mitral valve intervention should not be considered in non-severe mitral valve insufficiencies (without papillary rupture or chorda rupture) after AMI. The higher incidence of insufficiency after the use of isolated mitral annular ring due to left ventricular remodeling makes mitral annular ring less of a treatment option in the acute process.


  • Open Access

    Clinical outcomes of isolated redo mitral valve replacement in patients with mitral prosthetic heart valve dysfunction

    by Ahmet Güner, Ersin Kadiroğulları, Taner İyigün, İsmail Gürbak, Burak Onan, Ünal Aydın, Mustafa Gürsoy, Mehmet Ertürk

    Objectives: Redo mitral valve replacement (redo-MVR) represents a clinical challenge due to a higher rates of peri-operative morbidity and mortality. Patients and Methods: This retrospective study enrolled a total of 103 patients who underwent isolated redo-MVR due to prosthetic valve dysfunction. Patients who had an isolated bypass, low echocardiographic quality, history of repeated re-replacements (more than twice), paravalvular leak repair without preoperative and intraoperative transesophageal echocardiography examination, isolated congenital surgery or isolated open-heart surgical intervention (of any type) without a valve procedure at their first or later operations were excluded. The primary endpoint of the study was in-hospital death. Secondary endpoint included individual morbidity. Results: A total of 103 patients (mean age: 50.7 13.4 years; male: 58) who underwent isolated redo-MVR were enrolled in this study. The most common complaint of the patients at admission was obstruction or heart failure-related symptoms (80.6%) and the primary indication for redo-MVR was prosthetic valve thrombosis in 58 patients (56.3%). In-hospital mortality was 12.6% (13 patients). The post-operative complications included major bleeding (n=11) post-operative infection (sepsis, mediastinitis, pneumonia, wound infection, n=15), low cardiac output syndrome (n=10), acute kidney injury (n=17), pericardial effusion with tamponade (n=10), pleural effusion requiring hospitalization and drainage (n=18), ischemic stroke (n=4), fatal ventricular arrhythmia (n=1), peripheral embolism (n=1), moderate to severe paravalvular leak (n=5). There was not any catastrophic heart laceration. Conclusion: In-hospital mortality and complications of the isolated redo-MVR in our center are acceptable. With a well-defined protocol and appropriate patient selection, mortality in emergencies cases may be reduced.